Cantor Fitzgerald Analysts Boost Earnings Estimates for RIGL

1 day ago · Cantor Fitzgerald currently has a "Neutral" rating and a $25.00 target price on the stock. The consensus estimate for Rigel Pharmaceuticals' current full-year earnings is $0.17 per share. ... Piper Sandler boosted their price target on Rigel Pharmaceuticals from $15.00 to …

$25.00
OFF

Cantor Fitzgerald Analysts Boost Earnings Estimates For RIGL

1 week from now

marketbeat.com

$25
OFF

Rigel Pharmaceuticals Price Target Raised To $25 From $15 At …

1 week from now

Dec 10, 2024 · Cantor Fitzgerald raised the firm’s price target on Rigel Pharmaceuticals (RIGL) to $25 from $15 and keeps a Neutral rating on the shares. Rigel announced initial data from the …

nasdaq.com

$25
OFF

Rigel Pharmaceuticals Reports Preliminary Q4 Results; Issues 2025 ...

1 week from now

3 days ago · Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor Fitzgerald. TipRanks 34d. Rigel Pharmaceuticals price target lowered to $20 from $27 at B. Riley. …

businessinsider.com

$200
OFF

Rigel Pharmaceuticals Sees FY25 Revenue $200M-$210M, …

1 week from now

4 days ago · Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor Fitzgerald; Rigel Pharmaceuticals price target lowered to $20 from $27 at B. Riley; Rigel Pharmaceuticals …

businessinsider.com

$57
OFF

Rigel Pharmaceuticals Sees Q4 Revenue $57.6M, Consensus $47.42M

1 week from now

4 days ago · Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor Fitzgerald; Rigel Pharmaceuticals price target lowered to $20 from $27 at B. Riley; Rigel Pharmaceuticals …

businessinsider.com

$15.00
OFF

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives ... - MarketBeat

1 week from now

Jan 3, 2025 · Cantor Fitzgerald increased their price target on shares of Rigel Pharmaceuticals from $15.00 to $25.00 and gave the company a "neutral" rating in a research report on …

marketbeat.com

$15.00
OFF

Cantor Fitzgerald Issues Positive Forecast For Rigel Pharmaceuticals ...

1 week from now

Dec 11, 2024 · Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) had its target price lifted by Cantor Fitzgerald from $15.00 to $25.00 in a research report released on Tuesday …

etfdailynews.com

$25
OFF

RIGL Stock Price | Rigel Pharmaceuticals Inc. Stock Quote (U.S.: …

1 week from now

4 days ago · Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor Fitzgerald Dec. 10, 2024 at 9:40 a.m. ET on TipRanks.com Rigel Pharmaceuticals price target lowered to $20 …

marketwatch.com

$25
OFF

Rigel Pharmaceuticals (RIGL) News Today - MarketBeat

1 week from now

Jan 10, 2025 · Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor Fitzgerald. December 11, 2024 | markets.businessinsider.com ... B. Riley upped their target price on Rigel …

marketbeat.com

$15.00
OFF

Cantor Fitzgerald Boosts Rigel Pharmaceuticals (NASDAQ:RIGL) …

1 week from now

Dec 13, 2024 · Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) had its target price hoisted by Cantor Fitzgerald from $15.00 to $25.00 in a report published on Tuesday,Benzinga …

americanbankingnews.com

$34.20
OFF

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives $34.20 …

1 week from now

Dec 14, 2024 · Cantor Fitzgerald boosted their price target on shares of Rigel Pharmaceuticals from $15.00 to $25.00 and gave the stock a “neutral” rating in a research report on Tuesday.

etfdailynews.com

$23
OFF

Rigel Pharmaceuticals Price Target Raised To $23 From $15 At Piper ...

1 week from now

Nov 14, 2024 · Piper Sandler analyst Allison Bratzel raised the firm’s price target on Rigel Pharmaceuticals (RIGL) to $23 from $15 driven by pipeline developments. The firm keeps a …

nasdaq.com

$15.00
OFF

Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Pass Above 200

1 week from now

Dec 26, 2024 · Cantor Fitzgerald boosted their target price on Rigel Pharmaceuticals from $15.00 to $25.00 and gave the company a "neutral" rating in a research note on Tuesday, December …

marketbeat.com

$200
OFF

Strong Commercial Performance And Promising Pipeline Drive …

1 week from now

3 days ago · Rigel Pharmaceuticals sees FY25 revenue $200M-$210M, consensus $193.51M; ... Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor Fitzgerald; SHARE THIS …

businessinsider.com

$25
OFF

Rigel Granted Orphan Status For Myelodysplastic Syndromes

1 week from now

Jan 7, 2025 · Try Now>>See Insiders’ Hot Stocks on TipRanks >> Read More on RIGL:Rigel Pharmaceuticals price target raised to $25 from $15 at Cantor FitzgeraldRigel …

nasdaq.com

$25.00
OFF

Rigel Pharmaceuticals Price Target Raised To $25.00/Share From …

1 week from now

Rigel Pharmaceuticals Price Target Raised to $25.00/Share From $15.00 by Cantor Fitzgerald. Dow Jones ...

webull.com

$36.20
OFF

Rigel Pharmaceuticals (RIGL) Stock Forecast & Price Target

1 week from now

Jan 8, 2025 · According to the 5 analysts' twelve-month price targets for Rigel Pharmaceuticals, the average price target is $36.20. The highest price target for RIGL is $57.00, while the …

marketbeat.com

$200
OFF

Rigel Provides Business Update And 2025 Outlook - Morningstar

1 week from now

4 days ago · 2025 Outlook. Rigel anticipates 2025 total revenue of approximately $200 to $210 million, including:. Net product sales of approximately $185 to $192 million; Contract revenues …

morningstar.com

$27
OFF

Rigel Pharmaceuticals Price Target Raised To $27 From $17 At B. Riley

1 week from now

Dec 6, 2024 · B. Riley raised the firm’s price target on Rigel Pharmaceuticals (RIGL) to $27 from $17 and keeps a Neutral rating on the shares. ... Rigel Pharmaceuticals price target raised to …

businessinsider.com

$168.25
OFF

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised

1 week from now

2 days ago · Madrigal Pharmaceuticals has a fifty-two week low of $168.25 and a fifty-two week high of $368.29. The firm's 50 day moving average price is $319.52 and its two-hundred day …

marketbeat.com

FAQs about Cantor Fitzgerald Analysts Boost Earnings Estimates for RIGL Coupon?

What is Cantor Fitzgerald's price target on Rigel Pharmaceuticals?

Cantor Fitzgerald boosted their price target on shares of Rigel Pharmaceuticals from $15.00 to $25.00 and gave the stock a “neutral” rating in a research report on Tuesday. ...

What is the price target for Rigel Pharmaceuticals (Rigl)?

The highest price target for RIGL is $57.00, while the lowest price target for RIGL is $23.00. The average price target represents a forecasted upside of 76.07% from the current price of $20.56. Enter your email address to receive the latest news and analysts' ratings for Rigel Pharmaceuticals and its competitors. DeFi Coin on Verge of Breakout! ...

Should you buy Rigel Pharmaceuticals stock?

The consensus among Wall Street research analysts is that investors should "hold" RIGL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RIGL, but not buy additional shares or sell existing shares. Does Rigel Pharmaceuticals's stock price have much upside? ...

What is the forecast for Rigel Pharmaceuticals stock?

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Rigel Pharmaceuticals is $36.20, with a high forecast of $57.00 and a low forecast of $23.00. Should I buy or sell Rigel Pharmaceuticals stock right now? ...

How do I receive news & ratings for Rigel Pharmaceuticals?

Receive News & Ratings for Rigel Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rigel Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter. ...

Why did Rigel Pharmaceuticals stock rise 9% in premarket trade?

Shares of Rigel Pharmaceuticals Inc. shot up 9% in premarket trade Wednesday after the company announced it had entered a license and supply agreement with Spain-based Grifols, S.A. to commercialize fostamatinib disodium... ...